With more than 90% of revenue coming from pharma and biotech companies outside the top 25, CRO SynteractHCR is seeing more growth stemming from an influx of funding to smaller biotech companies, CEO Wendel Barr told us on the third day of the 51st annual...
Growing demand has prompted tableting specialist Meldex
International, formerly BioProgress, to launch a new sales and
distribution hub in Germany, with the UK firm also announcing a new
manufacturing contract for its XGel film.